|
⚲
|
| Keyboard |
| Flaum Sander A
✚
|
|
|---|---|
| CIK # | 0001261026 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001261026] | |
| 4 | [0001261026] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Eagle Pharmaceuticals Inc | |
| Flaum Sander A |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Eagle Pharmaceuticals Inc EGRX
Stock Option (right to buy) · derivative
|
2019-03-05 | Option exercise | 2,340 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock
|
2019-03-05 | Option exercise | 2,340 | $4.04 | 9,454 |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock
|
2019-03-05 | Tax withheld | 204 | $48.89 | 9,974 |
|
Eagle Pharmaceuticals Inc EGRX
Stock Option (right to buy) · derivative
|
2019-01-23 | Grant | 10,000 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock
|
2018-03-06 | Sell | 2,340 | $53.94 | 126,220 |
|
Eagle Pharmaceuticals Inc EGRX
Stock Option (Right to Buy) · derivative
|
2018-03-05 | Option exercise | 2,340 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock
|
2018-03-05 | Option exercise | 2,340 | $0.90 | 2,106 |
|
Eagle Pharmaceuticals Inc EGRX
Stock Option (Right to Buy) · derivative
|
2018-01-07 | Grant | 10,000 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Stock Option (right to buy) · derivative
|
2017-01-04 | Grant | 10,000 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock
|
2016-11-28 | Sell | 5,000 | $78.66 | 393,300 |
|
Eagle Pharmaceuticals Inc EGRX
Stock Option (right to buy) · derivative
|
2016-01-04 | Grant | 15,000 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock
|
2015-12-22 | Sell | 3,225 | $93.76 | 302,376 |
|
Eagle Pharmaceuticals Inc EGRX
Stock Option (right to buy) · derivative
|
2015-04-21 | Grant | 10,000 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock
|
2015-03-20 | Sell | 9,800 | $42.00 | 411,600 |
|
Eagle Pharmaceuticals Inc EGRX
Option (right to buy) · derivative
|
2015-03-13 | Grant | 5,000 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Stock Option (right to buy) · derivative
|
2014-04-08 | Grant | 4,680 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock, $0.001 par value
|
2014-02-18 | Conversion | 8,572 | ||
|
Eagle Pharmaceuticals Inc EGRX
Common Stock, $0.001 par value
|
2014-02-18 | Conversion | 2,887 | ||
|
Eagle Pharmaceuticals Inc EGRX
Series B Convertible Preferred Stock · derivative
|
2014-02-18 | Conversion | 8,580 | ||
|
Eagle Pharmaceuticals Inc EGRX
Series B-1 Convertible Preferred Stock · derivative
|
2014-02-18 | Conversion | 8,572 | ||
| showing 20 of 22 most recent transactions | |||||